Status:

COMPLETED

Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)

Lead Sponsor:

Azienda Unita' Sanitaria Locale Di Modena

Collaborating Sponsors:

University of Modena and Reggio Emilia

Azienda USL Reggio Emilia - IRCCS

Conditions:

Amyotrophic Lateral Sclerosis

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

ErmoSLA is a multicentric, randomized, controlled trial to compare effects of an "intensive" or "standard" motor rehabilitation treatment on motor disability in people with ALS

Detailed Description

The study is a multicentric, randomized, controlled trial to compare effects of standard versus intensive motor rehabilitation treatment for people with ALS. Eligible patients are going to be randoml...

Eligibility Criteria

Inclusion

  • Diagnosis of possible, probable or definite ALS according to the Revised El Escorial Criteria
  • Time from diagnosis \<18 months at screening.
  • Forced vital capacity (FVC)\> 50% at screening
  • Written informed consent
  • Patients will be required to take the full dose of Riluzole, but not assuming Riluzole do not constitute a criterion for exclusion.

Exclusion

  • Enrolment in any other clinical trial in the three months prior to screening
  • Tracheostomy or NIV for\> 23h/day for 14 consecutive days at screening.
  • Diagnosis of severe neurodegenerative diseases in addition to the ALS
  • Diagnosis of severe heart disease, current neoplasia, any unstable medical condition that contraindicates an intensive rehabilitation treatment
  • State of pregnancy or breastfeeding
  • Residency outside Emilia-Romagna Region
  • Lack of multidisciplinary follow-up

Key Trial Info

Start Date :

January 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2018

Estimated Enrollment :

65 Patients enrolled

Trial Details

Trial ID

NCT02306109

Start Date

January 1 2015

End Date

April 1 2018

Last Update

August 7 2018

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Department of Neuroscience, S. Anna Hospital

Ferrara, Italy

2

Department of Neuroscience, S.Agostino-Estense Hospital

Modena, Italy

3

Department of Neuroscience, IRCCS Arcispedale Santa Maria Nuova

Reggio Emilia, Italy